Latest News - Thermo Fisher Scientific
Top Corporates Hub
Thermo Fisher Scientific
The Zacks Analyst Blog Highlights Cisco, Lam, Thermo Fisher Scientific, Ampco-Pittsburgh and Catalyst
17.09.2026 07:45
Cisco, Lam Research and Thermo Fisher highlight AI, networking and life-science demand, while microcaps Ampco-Pittsburgh and Catalyst Bancorp offer added depth.
The Zacks Analyst Blog Highlights Cisco, Lam, Thermo Fisher Scientific, Ampco-Pittsburgh and Catalyst
17.09.2026 07:45
Cisco, Lam Research and Thermo Fisher highlight AI, networking and life-science demand, while microcaps Ampco-Pittsburgh and Catalyst Bancorp offer added depth.
Mayo Clinic and Thermo Fisher Scientific launch Precure, LLC to identify signs of disease before symptoms appear
15.09.2026 12:00
Mayo Clinic today announced the launch of Precure, LLC, with founding partner Thermo Fisher Scientific, the world leader in serving science, to help transform how the life sciences community understands the biological changes that occur as people move from health toward disease.
Oligonucleotide Synthesis Market Outlook 2026-2035 - Featuring Profiles of Thermo Fisher Scientific, Merck KGaA, and Integrated DNA Technologies
15.09.2026 11:41
Oligonucleotide Synthesis Gains Momentum as Precision Medicine, Gene Editing and Therapeutic Pipelines Drive GMP Capacity Expansion and PartnershipsDublin, Sept. 15, 2026 (GLOBE NEWSWIRE) -- "Oligonucleotide Synthesis Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035" has been added to ResearchAndMarkets.com's offering. Global Oligonucleotide Synthesis Market to Reach USD 8.6 Billion by 2035, Driven by Precision Medicine and Therapeutic Innovation The global oli
Single-Use Bioreactors Market by Product, Type, Cell Type, Molecule, Process Mode, Application, Competition, Region - Global Forecast to 2031
15.09.2026 08:55
The global single-use bioreactors market is forecast to grow from USD 5.43 billion in 2026 to USD 9.58 billion by 2031, at a 12.0% CAGR. Growth is driven by biologics, biosimilars, vaccine manufacturing, CDMO outsourcing, and flexible bioprocessing. Bioproduction and monoclonal antibodies led the market in 2025, while Asia Pacific is expected to grow fastest through 2031. Key players include Sartorius, Danaher, Thermo Fisher Scientific, and Merck KGaA.Dublin, Sept. 15, 2026 (GLOBE NEWSWIRE) -- "
Global Mass Spectrometry Market to Reach USD 10.78 Billion by 2031, Driven by Biologics, Precision Medicine and LC-MS/MS Adoption
15.09.2026 08:54
The global mass spectrometry market is projected to grow from USD 7.07 billion in 2026 to USD 10.78 billion by 2031, at an 8.8% CAGR. Growth is driven by precision medicine, biologics, multi-omics research, regulatory bioanalysis, and food and environmental testing. Instruments and LC-MS will lead the market, supported by high-resolution platforms, AI-enabled analytics, automation, and cloud-connected workflows. Pharmaceutical companies remain the largest end users, while Asia Pacific is expecte
Organoid Intelligence Market - Global Forecast to 2036; Biological Computing and Brain Organoids Drive Growth
10.09.2026 11:02
The global organoid intelligence market is projected to grow from USD 78.6 million in 2026 to USD 865.3 million by 2036, at a 27.1% CAGR. Growth is driven by advances in brain organoids, biological and biohybrid computing, stem cell engineering, AI, brain-on-a-chip systems, drug discovery and disease modeling. North America leads the market, while Asia-Pacific is expected to grow fastest. The report analyzes platforms, software, technologies, applications, end users, regional trends and key comp
Veterinary Diagnostic Markets Report Now Available — See Exactly How IDEXX, Zoetis, Antech, Roche, and Thermo Fisher Are Positioned to Win Through 2030
07.09.2026 10:38
249-Page Report Delivers Country-by-Country Forecasts Across 15 Markets, Competitive Profiles of 32 Companies, and the Investment-Grade Data You Need to Act With ConfidenceDublin, Sept. 07, 2026 (GLOBE NEWSWIRE) -- The "Veterinary Diagnostic Markets. Strategy & Trends with Forecasts by Assay Type, by Animal, by Application, by Place, by Product, and by Country 2026 to 2030" report has been added to ResearchAndMarkets.com's offering. The Veterinary Diagnostics industry is on a strong growth path
Thermo Fisher Scientific (NYSE:TMO) Shows Strong Technical Breakout Setup
07.09.2026 08:11
Thermo Fisher Scientific (TMO) shows a strong technical breakout setup with 9/10 ratings for trend and consolidation, near support with limited risk.
‘Corporate America Is Basically Exterminating Your Career.” Clark Howard’s Sounds Alarm For Americans In Their 50s, Who Want To Work Till 65
04.09.2026 14:35
Clark Howard named a specific age when corporate America tends to push workers out, and it falls years before most people's retirement plans even begin to account for income gaps, portfolio shortfalls, or Social Security decisions.
Should You Continue to Hold TMO Stock in Your Portfolio?
04.09.2026 14:35
Thermo Fisher's growth is gaining momentum as acquisitions strengthen its life sciences reach, but macro risks and competition remain concerns.
1 Healthcare Stock for Long-Term Investors and 2 We Ignore
04.09.2026 10:06
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 23.2% over the past six months, topping the S&P 500 by 11.5 percentage points.
Global Multiplex Assays Market 2026 Edition - Consumables Dominate Multiplex Assays with 68% Market Share
04.09.2026 09:48
The global multiplex assays market is projected to grow from US$6.8 billion in 2025 to US$12.4 billion by 2030, at a 12.8% CAGR. North America leads with a 34% share, while Asia Pacific is the fastest-growing region at 15.5%; India is forecast to expand at 16.9%. Consumables account for 68% of sales and protein multiplex assays hold 42%. Growth is driven by precision medicine, companion diagnostics, biomarker R&D, molecular diagnostics and laboratory automation. Key players include Thermo Fisher
Is This the Right Time to Add PBH Stock to Your Portfolio?
02.09.2026 13:38
Prestige Consumer Healthcare gains from acquisitions, e-commerce growth and strong cash flow, though currency swings and high debt remain key risks.
MBody AI Orchestrator Named Finalist for AI Deployment of the Year
02.09.2026 13:35
MBody AI’s hardware-agnostic platform was shortlisted alongside CrowdStrike, Lenovo and CVS Health in a category recognizing real-world AI deploymentISFIYA, Israel and LAS VEGAS, Sept. 02, 2026 (GLOBE NEWSWIRE) -- MBody AI Ltd. ("MBody AI" or the "Company") (NASDAQ: MBAI) today announced that its MBody AI Orchestrator™ platform has been shortlisted for AI Deployment of the Year in The 2026 A.I. Awards. The awards program is run by The Cloud Awards. The category recognizes the most impactful and
iMDx to Participate in Lake Street 10th Annual Best Ideas Growth “BIG10” Conference
02.09.2026 13:00
NASHVILLE, Tenn., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced participation in the upcoming Lake Street Capital Markets 10th Annual Best Ideas Growth “BIG10” Conference taking place September 10th, 2026 in New York. Event: Lake Street Capital Markets 10th Annual Best Ideas Growth “BIG10” ConferenceWho: Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea JamesDate: Thursday, September 10, 2026Location: Metropolit
Quantum Cyber Appoints Tzvi Lev as Head of Sales, Middle East to Lead GCC Commercial Expansion of Its Autonomous Defense Platform
02.09.2026 12:30
Former Israeli Consulate Economic Affairs Officer in Dubai, Founder of Israel’s Economic Division in the UAE Following the Abraham Accords, and Arabic-Speaking IDF Intelligence Analyst to Drive Government and Sovereign Engagement Across the GCC as Quantum Cyber Advances Its Israel-to-U.S. Battlefield-Proven Defense Technology StrategyNorwalk, CT, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (Nasdaq: QUCY) (“Quantum Cyber” or the “Company”), a Nasdaq-listed autonomous defense technology
Revvity (RVTY) Margins Story Faces A Valuation Test Following Its Zacks Upgrade
02.09.2026 12:06
Revvity (RVTY) is back in focus after a recent Zacks upgrade to Rank #2, which reflects improved earnings expectations even as questions remain about growth momentum and rising competitive pressure. Over the past year Revvity’s share price return has been strong, with a 30 day share price return of 12.5%, a 90 day share price return of 25.25% and a year to date share price return of 28.98%, while the 1 year total shareholder return is 44.46%. This suggests that positive momentum has been...
Neo Completes Transfer of Sarfartoq Interest to Greenland Mines
02.09.2026 12:00
Neo Performance Materials Inc. ("Neo" or the "Company") (TSX: NEO) (OTCQX: NOPMF) today announced the closing of the previously announced transaction under which its wholly-owned subsidiary, Neo North Star Holdings LLC ("NNSH"), together with the other shareholders of NNSR Holdings Inc. ("NNSR Holdings"), transferred all outstanding shares of NNSR Holdings and Neo North Star Resources, Inc., a wholly owned subsidiary of NNSR Holdings, via merger of NNSR Holdings to Greenland Mines Ltd. ("Greenla